News Biomerica, Inc.

Equities

BMRA

US09061H3075

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
0.6 ^USD	-4.78%		-15.85%	-52.00%

Apr. 29	Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	MT
Apr. 29	Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	Apr. 29	MT
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	Apr. 29	AQ
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	Apr. 29	CI
Biomerica Reports Third Quarter 2024 Financial Results	Apr. 15	AQ
Biomerica provides update on inFoods® IBS expansion	Apr. 15	AQ
Biomerica Provides Update on inFoods IBS Expansion	Apr. 15	CI
Biomerica Reports Third Quarter 2024 Financial Results	Apr. 12	AQ
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	Apr. 12	CI
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference	Mar. 28	AQ
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board	Feb. 21	AQ
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	Feb. 21	CI
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica	Jan. 23	AQ
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	Jan. 23	CI
Biomerica Reports Second Quarter 2024 Financial Results	Jan. 16	AQ
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	Jan. 16	CI
Top Premarket Decliners	Dec. 19	MT
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test	Dec. 18	DJ
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population	Dec. 18	AQ
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	Dec. 18	CI
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16	Nov. 10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biomerica, Inc.

Equities

BMRA

US09061H3075

Summary

Filters